🇮🇹 Part B: Multiple-dose ATM-AVI, Cohorts 1-4 in Italy

Part B: Multiple-dose ATM-AVI, Cohorts 1-4 (part-b-multiple-dose-atm-avi-cohorts-1-4) regulatory status in Italy.

Marketing authorisation

AIFA

  • Status: approved

Part B: Multiple-dose ATM-AVI, Cohorts 1-4 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in Italy

Frequently asked questions

Is Part B: Multiple-dose ATM-AVI, Cohorts 1-4 approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for Part B: Multiple-dose ATM-AVI, Cohorts 1-4 in Italy?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.